News

Recent Harvard Chan School MPH graduate Brandon Yan and CHDS faculty Ankur Pandya published a cost-effectiveness analysis of the new 2022 guideline-directed therapy for heart failure with reduced

The monetary value of a reduction in mortality risk is often quantified using one of three concepts: the “value per statistical life” (VSL),“value per statistical life year” (VSLY),

Despite considerable efforts to reduce oral health disparities, poor oral health and quality of dental care continue to disproportionately affect minority and publicly insured children.

At the inaugural Harvard Climate Symposium, CHDS Deputy Director Lisa Robinson participated in a panel on the threats posed by extreme heat, emphasizing the importance of thinking carefully

Researchers from the National Cancer Institute, led by Meredith S. Shiels, have outlined opportunities to prevent, detect, and treat common cancers in order to achieve the Cancer MoonshotSM goal

Edward Henry, doctoral student at the University of Galway, presented a set of new recommendations for incorporating “health spillover” into the economic evaluations

CHDS faculty Jane Kim, Dean for Academic Affairs and K.T. Li Professor of Health Economics, has accepted the role of interim dean at the Harvard T.H. Chan School of Public Health.

The Society for Benefit-Cost Analysis 2023 annual conference featured work conducted by several CHDS researchers. Faculty member James Hammitt presented his work

The CHDS Cervical Cancer Team, led by CHDS faculty Jane Kim, presented their latest research findings at the 35th International Papillomavirus Conference (IPVC)

People living with type 2 diabetes have a higher risk of coronary heart disease (CHD). In a CHDS seminar, Bart Ferket discussed using risk stratification to prevent CHD among diabetics.